[{"id":"852151a9-cba1-4072-ae4f-f77c8a4d1517","acronym":"FWD1509","url":"https://clinicaltrials.gov/study/NCT05068024","created_at":"2021-10-05T20:00:15.364Z","updated_at":"2024-07-02T16:36:06.718Z","phase":"Phase 1/2","brief_title":"A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT05068024 - FWD1509","lead_sponsor":"Forward Pharmaceuticals Co., Ltd.","biomarkers":" EGFR • HER-2","pipe":" | ","alterations":" EGFR mutation • HER-2 mutation • EGFR exon 19 deletion • EGFR T790M • EGFR exon 20 insertion • EGFR L861Q • EGFR G719X • EGFR S768I • EGFR exon 20 mutation • HER-2 A775","tags":["EGFR • HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • HER-2 mutation • EGFR exon 19 deletion • EGFR T790M • EGFR exon 20 insertion • EGFR L861Q • EGFR G719X • EGFR S768I • EGFR exon 20 mutation • HER-2 A775"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FWD1509"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 08/23/2021","start_date":" 08/23/2021","primary_txt":" Primary completion: 10/30/2022","primary_completion_date":" 10/30/2022","study_txt":" Completion: 12/30/2025","study_completion_date":" 12/30/2025","last_update_posted":"2022-07-26"}]